LD-2 disclosure · 2nd Quarter - Report
JOHNSON & JOHNSON SERVICES INC
via JOHNSON & JOHNSON SERVICES, INC.
Client
- Location
- New Jersey · United States of America
Registrant
- Firm
- JOHNSON & JOHNSON SERVICES, INC.
- Location
- NEW BRUNSWICK, New Jersey, United States of America
Lobbying activities
14 issuesBudget/Appropriations
Issues related to: - Contact lens safety, peripheral artery disease, and stroke care, specifically to provisions regarding appropriations report language - Appropriations for Labor Health and Human Services - NIH funding
Lobbyistsmrs JANE MARGARET ADAMS · LEIF BRIERLEY · LARRY CAMM · DEANA MCRAE · TIMOTHY SWOPE · COLLEEN VIVALDI
TargetedSENATE · HOUSE OF REPRESENTATIVES
Consumer Issues/Safety/Products
Issues related to: - Counterfeit healthcare goods - Brand protection
LobbyistsLEIF BRIERLEY
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
- S 1375/HR 830, "HELP Copays Act", regarding all provisions. - PL 117-169, "The Inflation Reduction Act", regarding provisions impacting drug pricing and implementation. - PL 113-5 "Pandemic All Hazards Preparedness Reauthorization", regarding all provisions. - S 1355/HR 2940, "PASTEUR Act", regarding all provisions. - HR 3723, "Medical Device Electronic Labeling Act", regarding all provisions. - HR 2748, "Contact Lens Prescription Verification Modernization Act", regarding all provisions. - HR 4261, "Amputation Reduction and Compassion Act", regarding all provisions. - S 3131/HR 5539, "ORPHAN Cures Act", regarding all provisions. - HR 5372, "Expanding Access to Seniors Access to Lower Cost Medicines Act of 2023", regarding all provisions. - S 2305, "The Biosimilar Red Tape Elimination Act", regarding all provisions. - HR 1352, "Increasing Access to Biosimilars Act of 2023", regarding all provisions. - HR 7174, "Ensuring Pathways to Innovative Cures (EPIC) Act", regarding all provisions - HR 8574, the "340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act", regarding all provisions - HR 7384, "Creating Hope Reauthorization Act", regarding all provisions Issues related to: - Obesity - Biosimilars - Health equity and diversity in clinical trials - Myopia - Ambulatory surgical services - Access to sterilization capacity for medical technologies - Peripheral artery disease - Cardiovascular health - Stroke care - FDA medical device shortage reporting requirements - Alternative funding programs - PBM practices - Health care workforce wellbeing - Medicaid Drug Rebate Program - the SUSTAIN 340B Act